83970_USNuclearCorpLogo.jpg
US Nuclear Strategic Partner Pulmostics is Now Conducting Breast Cancer Clinical Trials
07 déc. 2022 08h30 HE | US Nuclear Corp.
LOS ANGELES, CA, Dec. 07, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – US Nuclear’s (OTC-QB: UCLE) strategic partner Pulmostics Ltd is a biotech start-up devoted to early screening women for breast...